Defeat Obesity & Diabetes Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -92.94%
- Profit Growth 90.88%
- Ebitda 97.71%
- Net Worth -4.74%
- Total Assets -37.52%
About Defeat Obesity & Diabetes
Defeat Obesity & Diabetes Private Limited (DODPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 February 2012 and has a history of 12 years and 11 months. Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Pallavi Shah and Poonam Shah serve as directors at the Company.
Company Details
-
Location
Pune, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85100PN2012PTC142247
-
Company No.
142247
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
13 Feb 2012
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Defeat Obesity & Diabetes?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pallavi Shah
|
Director | 10-Oct-2016 | Current |
|
Poonam Shah
|
Director | 13-Feb-2012 | Current |
Financial Performance of Defeat Obesity & Diabetes.
Defeat Obesity & Diabetes Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 92.94% decrease. The company also saw a substantial improvement in profitability, with a 90.88% increase in profit. The company's net worth dipped by a decrease of 4.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Defeat Obesity & Diabetes?
In 2017, Defeat Obesity & Diabetes had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Magicroast Qoffee Private LimitedPallavi Shah is a mutual person
-
Omedico Wellness India Private Limited
Pallavi Shah is a mutual person
-
Curecare Legacy Private Limited
Pallavi Shah is a mutual person
-
Loc Healthcare Llp
Poonam Shah is a mutual person
-
Sanjivani Biocare Private Limited
Poonam Shah is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Defeat Obesity & Diabetes?
Unlock and access historical data on people associated with Defeat Obesity & Diabetes, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Defeat Obesity & Diabetes, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Defeat Obesity & Diabetes's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
